Skip to main content Deutsch

Funded Projects

Sorry, this content is only available in German!
Dieser Inhalt ist ausschließlich auf Englisch verfügbar.

Comprehensive STRategies to tacKIE malignant tumors: from nanomedicine and theranostics to precision medicine / STRIKE

Project acronym: STRIKE
Project title: Comprehensive STRategies to tacKIE malignant tumors: from nanomedicine and theranostics to precision medicine / STRIKE
Project registration number: Grant agreement No 101072462
State funding provider: European Union
Programme: Horizon 2020
Start date: 2023-01-01
End date: 2026-12-31
Principal investigator: Claudia Kuntner-Hannes
URL: https://strike.unime.it/

Programme: Horizon / HORIZON-MSCA-2021-DN-01

The project STRIKE will increase excellence in research and training in nanomedicine medicine creating a new generation of entrepreneurial and innovative multidisciplinary researchers. New experimental aspects on design and synthesis of nanostructured magnetic materials will be applied to the development of innovative magnetic field-responsive nanoterapheutics for osteosarcoma (OS) combinational therapy. Moreover, the peculiar features of STRIKE nanomaterials will be exploited for liquid biopsy using biological samples of BRCA+ breast cancer (BC) patients. The cooperation among outstanding universities, research institutes and industries will provide the ESRs with trans-national exchanges and the most innovative research trainings in novel anticancer therapeutic strategies, including in vivo biological evaluation, imaging in OS and early diagnosis in breast cancer. STRIKE will provide enhanced career perspectives in academic and non-academic sectors for eight PhD students in highly innovative fields by interdisciplinary mobility among institutes and companies in eight European countries. 


STRIKE aims to: 

  1. trainee 8 highly skilled employable ESRs
  2. enhance interdisciplinary capacity and cooperation within the nanomedicine and precision medicine EU research networks
  3. strengthen EU’s competitiveness and growth in nanomedicine and precision medicine through the translation of the consortium research/innovation outputs
  4. provide novel anticancer therapeutic and imaging strategies for osteosarcoma
  5. develop advanced magnetic tools for early diagnosis of breast cancer